Avive+ Soft Tissue Matrix for Neuropathic Pain

JM
Overseen ByJohn M Le, MD, DDS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Radial forearm free flap (RFFF) reconstruction is commonly used for head and neck defects but is associated with donor-site morbidity, including neuropathic pain and sensory disturbance. This randomized controlled pilot study evaluates whether placement of a soft tissue matrix over the superficial radial nerve at the donor site reduces neuropathic pain and improves sensory outcomes compared to standard closure alone.

Who Is on the Research Team?

JM

John M Le, MD, DDS

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

Inclusion Criteria

I am 18 years old or older.
I am having head and neck reconstruction using an RFFF procedure.
* Treated at University of Alabama at Birmingham
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo radial forearm free flap (RFFF) harvest with either standard closure or Avive+ Soft Tissue Matrix placement

Immediate post-surgery

Follow-up

Participants are monitored for neuropathic pain, sensory function, and wound complications

6 months
Regular visits at 1, 3, 6, and 12 months

Extended Follow-up

Participants continue to be monitored for long-term outcomes such as sensory function and graft loss

Up to 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Avive+ Soft Tissue Matrix

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Avive+ InterventionExperimental Treatment1 Intervention
Group II: Standard Closure (Control)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+